Henry Waxman said...
Well, you mentioned the evergreening provision in your testimony.
Context
Waxman raises concerns about the potential for evergreening in drug exclusivity.
06/10/2014
Waxman raises concerns about the potential for evergreening in drug exclusivity.
06/10/2014